The Academy of Pharmaceutical Sciences
'Promoting the pharmaceutical sciences'


FDA approves label expansion for Shire?s HAE drug Cinryze.....           AdoRx raises $10m funding to discover new cancer therapeutics.....           Ironwood Pharmaceuticals starts phase III program for IW-3718 in persistent gastroesophageal reflux disease.....           After making $1M+ on illegal trades, former Puma Biotechnology executive gets prison term.....           Shire scores new FDA thumbs-up for HAE drug Cinryze in latest bid to fend off rival CSL.....           Novartis pads Cosentyx's psoriatic arthritis lead with joint-damage label update.....           GlaxoSmithKline limits Shingrix orders, delays TV commercials amid 'unprecedented' demand.....           Novo Nordisk's oral semaglutide impresses analysts against Victoza, Januvia.....           Novo Nordisk?s semaglutide succeeds in two phase 3a type 2 diabetes trials.....           Novacap to acquire US-based CDMO PCI Synthesis.....           Report says smart pills will gain grounds in diagnostics and health monitoring applications.....           Lions Health, Day 2: Fear factors, pharma humor and how can we win next year?.....           Opioid maker Purdue deep-sixes sales team amid mass layoff and mounting legal woes.....           Drug shortages again on the rise after 5 years of improvements, FDA says.....           Why is AbbVie?s tax rate so low? Humira patents cached in Bermuda: Reuters.....           CVC weighs $3B-plus Recordati buy, but family and political drama could scuttle talks: FT.....           Can-Fite delays phase 2 trial of liver cancer drug Namodenoson.....           Decibel Therapeutics raises $55m in new funding round.....           Alexion seeks approval from FDA for PNH drug ALXN1210.....           Big Pharma executives jump to China startups for higher pay and more say: report.....           Pfizer?s 'Living With Cancer' wowed Cannes attendees, if not the pharma jury.....           AbbVie put gaming gremlins to work mining people?s ?fear of finding out? they?re sick.....           Lions Health: Mylan CEO talks big and small creative ideas that make a difference.....           What's next for embattled Allergan? Depends on pipeline performance, analysts say.....           Sanofi recruits veteran French auto executive to replace outgoing CFO Contamine.....           Universal flu vaccine biotech seeks Big Pharma partnership for phase 3 testing: CEO.....           Sanofi agrees to license infectious disease assets to Evotec.....           ImmunoGen gets FDA fast track status for mirvetuximab soravtansine to treat platinum-resistant ovarian cancer.....           NeuroVive grants LHON therapy license to BridgeBio Pharma.....           £56m medicines manufacturing innovation center to be established in Scotland.....           Futility forces Teva to halt fremanezumab?s chronic cluster headache study.....           BMS? elotuzumab / pomalidomide improves progression-free survival in cancer trial.....           Celltrion resubmits aBLA to FDA for proposed Trastuzumab biosimilar.....           X4P-001-RD demonstrates promising activity in WHIM syndrome patients.....           Cannes Lions Health: Merck, Novartis, Pfizer and 15 more pharmas nab shortlist honors.....           Dr. Reddy's forced to stop Suboxone generic rollout amid Indivior patent dispute.....           Allergan and actress Shay Mitchell quiz women on birth control facts.....           Corporate responsibility investor group touts support of first-year resolutions over executive pay, drug pricing.....           Bristol-Myers, AbbVie eye new use for myeloma drug Empliciti after phase 2 combo win.....           No pharma Grand Prix?again?at Cannes Lions Health, but record number of awards for drugmakers.....           Publicis executive Matt McNally takes on rebuilding as Outcome Health CEO.....           Kickoff to Lions Health: New chances for pharma in awards, exposure and recruiting.....           Another poll finds dropoff in pharma consumer confidence.....           Faron Pharmaceuticals reports inconsistent Traumakine biomarker results.....           Faron Pharmaceutics reports inconsistent Traumakine biomarker results.....           Novartis targets Johnson & Johnson's Remicade, Amgen's Enbrel with biosimilar switching data.....           NICE dogs Roche's Perjeta again, this time in postsurgery breast cancer patients.....           FiercePharmaAsia?Sun?s key Halol plant, Eisai?s new Alzheimer?s center, Takeda-Shire opponents.....           Mylan scores FDA approval of generic Suboxone for opioid addiction, but a strong launch is no sure bet.....           Bristol-Myers? Opdivo ushers in a new era as the first I-O therapy approved in China.....           U.K. cost watchdogs turn away rare disease med Crysvita.....           ViiV?s dolutegravir/lamivudine regimen succeeds in two phase 3 HIV-1 trials.....           Sage, Shionogi to collaborate on MDD drug in three Asian countries.....           Faron?s FRDS treatment Traumakine fails to produce consistent interferon-beta bioactivity in phase III trial.....           Can Sanofi compete in lung cancer? With I-O med cemiplimab, it?s aiming for third.....           Can Sanofi compete in lung cancer? With I-O med cemiplumab, it?s aiming for third.....           Talc attorney says J&J used law firm to shield contribution for journal article.....           Can Sanofi compete in lung cancer? With I-O med cemiplumab, it?s aiming for third.....           Massachusetts lawsuit names Purdue CEOs, Sackler family for alleged role in opioid epidemic.....           Merck's Keytruda nabs 2nd approval in 2 days, this time in non-Hodgkin lymphoma.....           Allergan brings in Abbott veteran for board position after investors demand change.....           FDA strikes down Mylan's generic Advair?again?citing 'minor' issues.....           Flex Pharma to stop two neuromuscular disease trials over safety concerns.....           FDA approves Roche's Avastin plus chemotherapy for ovarian cancer after surgery.....           Recipharm agrees to acquire Sanofi CMO business in UK.....           RSS NEWSFEED....
Welcome to
The Academy of
Pharmaceutical Sciences
 
The Academy of Pharmaceutical Sciences (APS) is the UK-based professional membership body for Pharmaceutical Scientists.

We represent individuals and organisations from around the globe, throughout their development, in the delivery of excellence in the Pharmaceutical Science sector.
 
 
 
 
Latest news

Call for Nominations for the Eminent Fellowship and Fellowship of the Academy of Pharmaceutical Sciences (APS)

The APS is proud to announce a call for this yearís Nominations for two awards, the

  • Eminent Fellowship (Nominated by an APS member)

  • Fellowship of the Academy (Self-Nominated by an APS member)

These awards recognise and reward science from all sectors where Pharmaceutical Scientists work. The eminent fellowship will be presented at a social networking event held on Thursday 6th September followed by this yearís premier UK Pharmaceutical Sciences Conference, APS@FIP conference in 2018 which will take place in Glasgow on the 7th September 2018.

For more information, click here

Professional recognition for Pharmaceutical Science Degrees

The Academy of Pharmaceutical Sciences (APS) is delighted to announce that the pharmaceutical science course at the University of Greenwich has become the first APS accredited course having successfully completed the accreditation process set up by the Academy towards the end of 2017.

This is the first time that a pharmaceutical science course has been accredited in the United Kingdom and it is also, we believe, a world first.

Achieving accreditation gives assurance to students and employers that the course meets the high standards required by the Academy and that these standards will be maintained throughout the 5-year period of accreditation.

APS believes that the accreditation process will raise the profile of pharmaceutical sciences in both academia and industry. The discipline is key in the discovery, development and manufacture of new medicines and as such is central to government initiatives to encourage the pharmaceutical industry to maintain and strengthen its strong base here in the UK.

The Academy will continue to work with other stakeholders to build the science base for the ultimate benefit of patients.

 
 
APS events overview

The APS has developed an exciting and informative programme for our events in 2018.

Donít forget to make a note of APS@FIP, linking with the 78th FIP World Congress of Pharmacy and Pharmaceutical Science conference.

Please take a look at our programme, with event summaries, below:

Nanomedicines for the Delivery of Biologics
18 July 2018 - University of Reading
Under the auspices of APS, with special insight from the Nanomedicine focus group, we are proud to announce this new one-day special symposium. This one-day symposium builds on the Recent Emerging Technologies in Therapeutic Oligonucleotides conference in Cambridge, March 2018. We are bringing together world-class speakers with expertise in nanomedicines for the delivery of biologics spanning from bench to bedside. We have assembled an outstanding speaker line-up which includes, but is not limited to, Prof Awyn Jones (University of Cardiff), Prof Yvonne Perrie (University of Strathclyde) and Prof Len Seymour (University of Oxford).
To learn more and to register, click here

APS@FIP
7 September 2018 - Hilton Hotel, Glasgow
Linking with the 78th FIP World Congress of Pharmacy and Pharmaceutical Science conference, which will take place in the city from the 2 - 6 September 2018. The theme of this conference in 2018 is 'The Science of Differentiated Medicines'.
To learn more and to register, click here

OTHER EVENTS IN DEVELOPMENT
OrBiTo (Innovative Tools for Oral Biopharmaceutics) Conference
Developability for Biologicals
Inhaled Workshop
Basic Biopharmaceutics workshop 


Follow us
 
Upcoming Events
APS Nanomedicines for the Delivery of Biologics
18 July 2018
APS@FIP
7 September 2018
10th APS International PharmSci conference 2019
11 - 13 September 2019
Job Vacancies
View all Vacancies
Advertise your job vacancies
The APS is grateful for the support of:
Join Us

Join the academy and get discounts on events, post-nominals, latest news and more.

 

The Academy of Pharmaceutical Sciences
Unit Q, Troon Way Business Centre
Humberstone Lane, Leicester, LE4 9HA
Tel: 0116 274 7351, Fax: 0116 274 7365, Email: info@apsgb.org

Terms of use:
The material included on this site is provided for information purposes only, and we make no representations or warranties as to its accuracy. Before relying on this material, you should take care to verify its accuracy, taking professional advice as appropriate.

Privacy Policy:
For details on the data we collect and how we store and process your data please refer to our Privacy Policy.